NCT01686282

Brief Summary

Cardiovascular disease (CVD) continues to be the leading cause of death in the U.S. Americans have been more concerned about their blood cholesterol levels and dietary cholesterol intakes rather than their overall cardiovascular health risk factors leading to CVD such as hypertension, vascular dysfunction, inadequate consumption of fruits and vegetables and physical activity. Statistics show that approximately 91% of individuals with CVD have vascular dysfunction which is attributed to endothelial and autonomic dysfunction leading to increased arterial stiffness. The investigators long-term goal is to provide feasible and effective dietary ways for pre- and stage 1- hypertensive individuals to normalize their blood pressure (BP), improve vascular function and thereby reducing their cardiovascular risk and enhancing the quality of life. Blueberries are a rich source of phenolic compounds and these compounds may play an important role in promoting cardiovascular health. Considering the strong possibility that phytochemicals present in blueberry work additively or synergistically, it would be ideal to investigate the cardioprotective effects of blueberry as a whole. The investigators overall objective to bring forth evidence that blueberry consumption will reduce BP and cardiovascular risk factors including endothelial dysfunction, arterial stiffness, and autonomic dysfunction in pre- and stage 1-hypertensive postmenopausal women. The investigators hypothesize that blueberry supplementation will improve vascular function and will lower blood pressure in postmenopausal women with pre-hypertension. The findings of this study will provide a foundation for disseminating feasible, safe approaches for preventing and combating hypertension at its early stage which does not require drug therapy.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
48

participants targeted

Target at P25-P50 for phase_2

Timeline
Completed

Started Jan 2012

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2012

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

September 11, 2012

Completed
7 days until next milestone

First Posted

Study publicly available on registry

September 18, 2012

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2013

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2014

Completed
Last Updated

January 14, 2015

Status Verified

January 1, 2015

Enrollment Period

1.2 years

First QC Date

September 11, 2012

Last Update Submit

January 12, 2015

Conditions

Keywords

Blood pressureArterial StiffnessBlueberry SupplementationAortic Blood PressureHypertensionPostmenopausalPulse Wave Velocity

Outcome Measures

Primary Outcomes (1)

  • Blood Pressure

    By measuring aortic blood pressure at rest and during physiological stress (handgrip exercise and post-exercise muscle ischemia).

    8 weeks

Secondary Outcomes (6)

  • Autonomic Control of Blood Pressure

    8 weeks

  • Autonomic Control of Heart Rate

    8 weeks

  • Endothelial Function

    8 week

  • Inflammation

    8 weeks

  • Oxidative Stress

    8 weeks

  • +1 more secondary outcomes

Study Arms (2)

Placebo

PLACEBO COMPARATOR

8 weeks of freeze-dried blueberry powder taken in two doses of 22g each per day.

Dietary Supplement: Placebo

Blueberry

EXPERIMENTAL

8 weeks of freeze-dried blueberry powder taken in two doses of 22g each per day.

Dietary Supplement: Freeze-dried Blueberry Powder

Interventions

8 weeks of freeze-dried taken in two doses of 22g each per day.

Also known as: U.S. Highbush Blueberry Council
Blueberry
PlaceboDIETARY_SUPPLEMENT

8 weeks of freeze-dried taken in two doses of 22g each per day.

Placebo

Eligibility Criteria

Age45 Years - 65 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • women (1 to 10 years after natural menopause or bilateral oophorectomy) 45-65 years of age.
  • Seated blood pressure ≥ 130/85 mm Hg but ≤ 160/90 mm Hg.

You may not qualify if:

  • Blood pressure \>160/100 mmHg
  • Taking insulin
  • Cardiovascular disease
  • Active cancer
  • Asthma
  • Glaucoma
  • Thyroid disease
  • Kidney disease
  • Liver disease
  • Pancreatic disease
  • Enrollment in a weight loss program
  • Heavy smokers (\>20 cigarettes per day)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Department of Nutrition, Food, and Exercise Sciences, Florida State University

Tallahassee, Florida, 32306, United States

Location

Related Publications (1)

  • Johnson SA, Figueroa A, Navaei N, Wong A, Kalfon R, Ormsbee LT, Feresin RG, Elam ML, Hooshmand S, Payton ME, Arjmandi BH. Daily blueberry consumption improves blood pressure and arterial stiffness in postmenopausal women with pre- and stage 1-hypertension: a randomized, double-blind, placebo-controlled clinical trial. J Acad Nutr Diet. 2015 Mar;115(3):369-377. doi: 10.1016/j.jand.2014.11.001. Epub 2015 Jan 8.

MeSH Terms

Conditions

Hypertension

Condition Hierarchy (Ancestors)

Vascular DiseasesCardiovascular Diseases

Study Officials

  • Bahram H Arjmandi, PhD, RD

    Florida State University

    PRINCIPAL INVESTIGATOR
  • Arturo Figueroa, MD, PhD

    Florida State University

    PRINCIPAL INVESTIGATOR
  • Sarah A Johnson, PhD, RD, CSO

    Florida State University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, INVESTIGATOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Margaret A. Sitton Professor and Director of the Center for Advancing Exercise and Nutrition Research on Aging

Study Record Dates

First Submitted

September 11, 2012

First Posted

September 18, 2012

Study Start

January 1, 2012

Primary Completion

March 1, 2013

Study Completion

January 1, 2014

Last Updated

January 14, 2015

Record last verified: 2015-01

Locations